Golden Leaf Reports Fiscal Year 2017 Results

TORONTO, April 30, 2018/AxisWire/ Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced financial results for the fiscal year ended December 31, 2017, and a general business update.

2017 Business and Financial Highlights


Subsequent Events

Mr. William Simpson, Chief Executive Officer of Golden Leaf Holdings, commented on the year’s achievements, “In 2017, Golden Leaf’s management team and strategy underwent significant changes. In the first half of 2017, the Company embarked on a multi-acquisition strategy to diversify beyond its wholesale-focused footprint in the Portland, Oregon market. In particular, we acquired Chalice Farms to expand our retail exposure in Portland, the MMC and MMG companies to provide entry into Canada and purchased cultivation, extraction and sales licenses in Nevada.

“Over the second half of the year, we accomplished a great deal, completing and integrating these acquisitions, identifying and implementing cost reductions across the business, hiring key personnel to help stabilize operations and position the Company to advance on key strategic initiatives. While I am proud of our collective efforts to lay the groundwork for future growth, we also faced several headwinds, including  changes to city codes in Portland that delayed the receipt of our Portland processing license, from which we anticipate deriving higher margins on internally produced oils, and, most noticeably, severe capital constraints. As a result of the bought deal completed in January of 2018, as well as the extensive progress we have made securing cannabis licensing in our core – target markets, we believe we are now positioned to achieve meaningful and sustainable growth.”

“Golden Leaf is now focused on building our infrastructure responsibly and investing both organically and through accretive acquisitions to capitalize on the opportunities ahead of us. We are pleased to be moving forward on several major fronts, including expanding the Chalice Farms retail footprint in Oregon, introducing our new franchise model in Canada and the U.S., becoming a commercial entity in Canada, and most recently, announcing  our planned entry into California, the U.S.’s largest cannabis market. Furthermore, we expect expanded production potential capacity to enable us to roll out new wholesale products in all of these core markets. We remain confident in the opportunities that lie before us and in our ability to execute on our growth strategy.”

2017 Business Overview

  • Oregon:

The Company is consolidating its operations to the Chalice Farms campus in the Portland, Oregon area. The Company has made progress toward securing the required extraction license for its production facility in Portland, Oregon and the construction of a processing/ cultivation facility which is expected to be completed by the middle of 2018.

As a result of the successful acquisition and integration of the Chalice Farms dispensary chain, together with the opening of a new Chalice Farms-branded dispensary in December 2017, the Company now has six retail dispensaries in operation, with an additional location in Happy Valley, Oregon, that Golden Leaf expects to open in the second quarter of 2018. The Company launched its new Fruit Chews edible line in March, 2018 and plans to ramp up production in Oregon throughout the remainder of 2018.

  • Nevada: The Company has state cultivation and production/extraction licenses in Nevada, and currently cultivates unique strains of Chalice-branded products. After securing the requisite business licenses, the Company commenced sales of its high-quality, proprietary cannabis brands to dispensaries throughout the state in the third quarter of 2017. GLH’s products are currently selling in 30-40 stores across Nevada. The Company also has an agreement with a distributor in Reno, Nevada, to generate sales. As its production capabilities increase, the Company plans to roll out new product lines in Nevada throughout 2018. The Company also plans to open a retail dispensary in Nevada, contingent upon receiving a retail sales license.
  • Canada: In November, MMG was granted a cultivation license by Health Canada for its Ontario cannabis grow facility in St. Thomas, Ontario. In January, MMG commenced grow facility operations in preparation for the launch of retail operations in Canada. The Company anticipates its first harvest in May 2018 and has arranged to sell the produced flower upon the receipt of its sales license in Canada, which is expected in June 2018.

The Company closed the acquisition of Medical Marijuana Group Consulting Ltd. (MMC) in January 2018, a medical marijuana consulting company that secures high-value medical marijuana patients and educates and refers them to Licensed Producers for their product. To date, the relationship with MMC has generated the acquisition of approximately 3,500 active patients.

  • Franchise model: In March 2018, Golden Leaf formed the Chalice Farms Franchise model, and signed a letter of intent to enter into a collaboration with BlackShire Capital to drive the growth of the Chalice Farms retail footprint, initially in Canada, and subsequently in the U.S.
  • New management: In June 2017, Gary Yeoman was named Chairman of the Board of Directors. Following the acquisition of Chalice Farms in Oregon in July 2017, William Simpson was appointed Chief Executive Officer. In January 2018, Craig Eastwood joined the team as Chief Financial Officer. The Company has also hired a Director of Compliance to help it navigate the complex regulatory environment.

Fiscal Year Ended December 31, 2017 Financial Results

For the year ended December 31, 2017 (“FY 2017”), net revenue was $11.5 million USD as compared to $7.7 million USD for the same twelve-month period in 2016 (“FY 2016”). The 50% year-over-year increase largely reflects the contribution from product sales as a result of the acquisition of Chalice Farms in July 2017, more than offsetting supply constraints of key products across the portfolio.

Gross profit was $1.7 million USD, or 15% of net revenue, for FY 2017, compared with 1% of net revenue in FY 2016. Year-over year, gross margin benefitted from better utilization of production staff, consistent margins across product categories and the sale of retail products sold at acquired dispensaries.

Operating expenses were at $11.7 million USD for FY 2017, compared with $11.5 million in FY 2016. The Company identified opportunities to streamline the business and reduce its corporate overhead, which is expected to positively impact future payroll expense.

Other non-operating expenses were $46 million USD for the year ended December 31, 2017, compared to $9.9 million USD for the year ended December 31, 2016. The increase in non-operating expenses is due to higher transaction costs associated with acquisitions, a significant impairment of the assets acquired from BMF Washington, and losses on changes in fair value of warrant and debt liabilities.

Net loss for FY 2017 was $56.1 million USD, or $0.21 USD per share loss, compared with a net loss of $21.3 million USD, or $0.23 USD per share loss, for FY 2016. As a result of the recent acquisitions and financing transactions, the current number of common shares outstanding is 576,338,334.

As of December 31, 2017, the Company had approximately $6.0 million USD in cash, compared with $3.9 million USD at December 31, 2016. Subsequent to the end of FY 2017, Golden Leaf received approximately $17.5 million CAD from a private placement bought deal basis in January 2018.

Investor Conference Call

GLH’s management, led by Mr. William Simpson, Chief Executive Officer, will hold a conference call at 4:30 PM ET on today, Monday April 30, 2018, to report its financial results for the year ended December 31, 2017.

The dial-in information for the conference call is as follows:

Program Title: Golden Leaf Holdings Fiscal 2017 Earnings Call

Canada & U.S.: +1 (877) 423-9813

International: +1 (201) 689-8573

Participants must request the Golden Leaf Call.


A live audio webcast will be available online on the Company’s website at, where it will be archived for one year.

An audio replay of the conference call will be available through midnight May 14, 2018 by dialing +1 (844) 512-2921 from the U.S. or Canada, or +1 (412) 317-6671 from international locations, Conference ID: 13679015.

To be added to the Golden Leaf email distribution list, please email with “Golden Leaf” in the subject line.

About Golden Leaf Holdings:

Golden Leaf Holdings Ltd., a Canadian company with operations in Portland, Oregon, is one of the largest cannabis oil and solution providers in North America, and a leading cannabis products company built around recognized brands. Golden Leaf Holdings cultivates, extracts and manufactures and distributes its products through its branded Chalice Farm retail dispensaries, as well as through third party dispensaries. Golden Leaf leverages a strong management team with cannabis and food industry experience to complement its expertise in extracting, refining and selling cannabis oil.  Visit to learn more.


For further information, please contact:

Investor Relations:

Phil Carlson / Steve Silver

KCSA Strategic Communications

212-896-1233 / 212-896-1220


William Simpson
Chief Executive Officer
Golden Leaf Holdings

Cautionary Note Regarding Forward-Looking Information

Disclaimer: This press release contains “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the Company’s future business operation, expectations of gross sales, the opinions or beliefs of management and future business goals.  Statements regarding the impact of expanded production capacity, the completion of the Company’s processing/cultivation facility by the middle of 2018, the expected opening of a dispensary in Happy Valley, Oregon in the second quarter of 2018, plans to ramp up production throughout the remainder of 2018, rolling out new product lines in Nevada in 2018, opening a dispensary in Nevada, a first harvest at MMG in May 2018 and receipt of sales  licence by MMG in June 2018 are all forward looking information, subject to the risks noted herein. Generally, forward looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to general business, economic and competitive uncertainties, regulatory risks including risks related to the expected timing of the Company’s participation in the Adult Use market, market risks, risks inherent in manufacturing operations and other risks of the cannabis industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking information. Forward-looking information is provided herein for the purpose of presenting information about management’s current expectations relating to the future and readers are cautioned that such information may not be appropriate for other purpose. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws. This Release does not constitute an offer of securities for sale in the United States, and such securities may not be offered or sold in the United States absent registration or an exemption from registration or an exemption from registration.

Consolidated Statements of Operations and Comprehensive Loss        
For the years ended December 31, 2017 and December 31, 2016        
(Expressed in U.S. dollars)          
      2017   2016
 Product sales   Revenue $     10,411,232   $        7,241,554
 Royalties          1,100,066                419,934
Total Revenue $     11,511,298   $        7,661,488
 Inventory expensed to cost of sales            9,535,602             6,962,331
 Production costs            465,658                909,409
 Gain on changes in fair value of biological assets (198,000)   (276,135)
Cost of sales expense $       9,803,260   $        7,595,605
Gross profit $       1,708,038   $             65,883
General and administration          8,610,318             7,009,610
Share based compensation          1,239,670             1,026,504
Professional fees paid with equity instruments              80,436                668,615
Sales and marketing          1,114,628                892,436
Research and development                     –                185,136
Depreciation and amortization            572,695                208,922
Impairment of long-lived assets              50,254             1,555,612
Total expenses $     11,668,001   $      11,546,835
Loss before undernoted items $      (9,959,963)   $     (11,480,952)
Interest expense          1,549,780             1,216,586
Transaction costs          8,518,490             4,712,218
Loss on extinguishment                     –           11,215,118
Accretion interest expense                     –                665,772
Loss on disposal of assets            470,071                        –
Impairment of financing lease receivable            432,557                243,181
Impairment of intangible asset          9,350,000                        –
Impairment of purchase option          5,200,000                        –
Other loss            437,413                256,203
(Gain)Loss on change in fair value of warrant liabilities          7,714,578            (4,152,077)
(Gain)Loss on change in fair value of liabilities        12,296,260            (4,234,000)
Loss before income taxes (55,929,112)   (21,403,953)
Current income tax expense            143,230                (74,136)
Net Loss $    (56,072,342)   $     (21,329,817)
Other comprehensive loss      
 Reversal of unrealized loss on available for sale purchase option,      
    net of tax for impairment $          530,000   $                   –
 Items that will be reclassified subsequently to profit or loss:      
 Unrealized loss on available for sale purchase option, net of tax                     –               (530,000)
 Cumulative translation adjustment                9,828                        –
Comprehensive Loss     $    (55,532,514)   $     (21,859,817)
Basic and diluted loss per share     $              (0.21)   $               (0.23)
Weighted average number of common shares outstanding          262,011,877           91,207,720


Consolidated Statements of Financial Position      
As at December 31, 2017 and December 31, 2016    
(Expressed in U.S. dollars)      
  December 31, 2017   December 31, 2016
 Cash $                6,009,447   $                 3,940,463
 Accounts receivable                     377,746                          97,538
 Current portion of financing lease receivable                              –                          44,328
 Other receivables                              –                         369,937
 Income tax recoverable                     432,000                         575,000
 Sales tax recoverable                     442,832                         192,112
 Biological assets                       90,627                                 –
 Inventory                   3,623,255                         942,450
 Prepaid expenses and deposits                     348,176                         402,451
 Assets held for sale                     305,274                      2,156,000
Total current assets $              11,629,357   $                 8,720,279
Financing lease recievable                              –                         388,228
Available for sale purchase option                              –                      4,670,000
Property, plant and equipment                   5,956,910                      1,713,285
Intangible assets                 26,227,116                      9,350,000
Goodwill                 31,971,398                                 –
Total assets $              75,784,781   $               24,841,792
 Accounts payable and accrued liabilities $                2,867,735   $                 1,626,443
 Interest payable                       48,524                         188,200
 Current portion of long-term debt                     131,610                      1,489,172
 Current portion of convertible debentures      
      carried at fair value                     271,245                    10,315,555
 Related party notes payable                     389,916                      1,500,000
 Derivative liability                       61,044                                 –
Total current liabilities $                3,770,074   $               15,119,370
Long term debt 80,381                         109,905
Convertible debentures carried at fair value                 30,360,225                    12,132,000
Consideration payable                   9,527,350                                 –
Warrant liability 14,300,616                         416,414
Total liabilities $              58,038,646   $               27,777,689
Share capital $            108,552,681   $               34,282,314
Warrant reserve 5,083,561                      3,501,409
Share option reserve 1,087,640                         993,211
Shares to be issued                              –                         267,701
Contributed surplus 59,940                          59,940
Accumulated other comprehensive loss                         9,828   (530,000)
Deficit (97,047,515)   (41,510,472)
Total shareholders’ equity 17,746,135   (2,935,897)
Total liabilities and shareholders’ equity $              75,784,781   $               24,841,792



You Just Read:

Golden Leaf Reports Fiscal Year 2017 Results